What does CUSIP 872381108 represent in this 13F holders report?

CUSIP 872381108 is the security identifier for TELA - TELA Bio, Inc. - Class A Common Stock used to aggregate holder disclosures.

How many institutions held TELA - TELA Bio, Inc. - Class A Common Stock in Q3 2020?

43 institutional investors reported TELA - TELA Bio, Inc. - Class A Common Stock for Q3 2020. Use the holders table for investor-level position and value details.

TELA Bio, Inc. - Class A Common Stock (TELA)

CUSIP: 872381108

Q3 2020 13F Holders as of 30 Sep 2020

Security type / class: Equity / Class A Common Stock
Total 13F shares: 9,752,756
Total 13F value: $161,293,000
Share change: +7,412
SEC-reported price per share: $16.54
Number of holders: 43
Value change: +$2,115,756
Number of buys: 22
Number of sells: 26
Shares outstanding: 44,525,021

Security key

872381108

Report period

Q3 2020

Institutions

Top holders

TELA full security history Ownership snapshot Full 13F holder table TELA Bio, Inc. SEC filings TELA Bio, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TELA - TELA Bio, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

15/15

Latest evidence

30 Jun 2020

13F Lead comparable stake: 6.8% Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 6.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 6.8%

Essex Woodlands Management, Inc. 3.1%

RTW INVESTMENTS, LP 3.1%

Alyeska Investment Group, L.P. 1.6%

COWEN AND COMPANY, LLC 0.92%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	6.8%	$39,237,000 3,027,542 shares	—	30 Jun 2020
Essex Woodlands Management, Inc.	13F Company 13F	3.1%	$18,037,000 1,391,768 shares	—	30 Jun 2020
RTW INVESTMENTS, LP	13F Company 13F	3.1%	$17,682,000 1,364,358 shares	—	30 Jun 2020
Alyeska Investment Group, L.P.	13F Company 13F	1.6%	$9,392,000 724,703 shares	—	30 Jun 2020
COWEN AND COMPANY, LLC	13F Company 13F	0.92%	$5,306,000 409,417 shares	—	30 Jun 2020
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F Company 13F	0.73%	$4,212,000 325,000 shares	—	30 Jun 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,752,756

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

-6

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 value	Q3 2020 value	Value change	Value Chg %